{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:00:09Z","timestamp":1792166409073,"version":"4.4.0"},"reference-count":49,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024893","name":"Cambridge BHF Centre of Research Excellence","doi-asserted-by":"publisher","award":["RE\/24\/130011"],"award-info":[{"award-number":["RE\/24\/130011"]}],"id":[{"id":"10.13039\/501100024893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/F\/22\/110052"],"award-info":[{"award-number":["RG\/F\/22\/110052"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000143","name":"Alzheimer Society","doi-asserted-by":"publisher","award":["AS-RF-21-017"],"award-info":[{"award-number":["AS-RF-21-017"]}],"id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Stroke"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Epidemiological evidence suggests associations between substance use disorders and risk of stroke, but whether these are due to confounding or are true causal relationships remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To meta-analyze the observational evidence on illicit substance use and stroke risk and apply Mendelian randomization (MR) to evaluate potential causal effects of substance dependence on stroke subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of studies reporting associations between illicit drug use and stroke (PROSPERO registration\u2014CRD420251053702). The meta-analysis included 32 studies comprising more than 100 million total participants across administrative, hospital-based, and population-based datasets. Pooled odds ratios (ORs) were estimated using multivariate random-effects models for ischemic and hemorrhagic subtypes. We then performed two-sample MR using genome-wide association study summary statistics to examine associations between seven drug exposures and all stroke, ischemic and hemorrhagic stroke, and ischemic stroke subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Meta-analysis demonstrated significant associations of cannabis (OR = 1.37, 95% confidence interval (95% CI) = 1.14\u20131.65), cocaine (OR = 1.96; 95% CI = 1.27\u20133.01), and amphetamines (OR = 2.22, 95% CI = 1.40\u20133.53) with increased stroke risk, while no significant association was observed for opioids. Findings for cannabis showed some heterogeneity and small-study effects. MR analyses revealed that cannabis use disorder was associated with any stroke (OR = 1.11 [1.01\u20131.51]) and large artery stroke (OR = 1.35, 95% CI = 1.01\u20131.80), and cocaine dependence was associated with cardioembolic stroke (OR = 1.08, 95% CI = 1.02\u20131.14) and intracerebral hemorrhage (OR = 1.38, 95% CI = 1.15\u20131.65). Genetically predicted substance use disorder overall was associated with any stroke (OR = 1.33, 95% CI = 1.02\u20131.72) and intracerebral hemorrhage (OR = 7.79, 95% CI = 3.46\u201317.54). Problematic and dependent alcohol use was linked to large artery and cardioembolic stroke, whereas nicotine dependence showed no significant associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings provide consistent observational and genetic evidence that several forms of substance misuse increase stroke risk, particularly cocaine, amphetamines, and cannabis. These findings suggest important public health implications for prevention strategies targeting substance use disorders to mitigate stroke risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17474930261418926","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:54:52Z","timestamp":1769057692000},"page":"788-800","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Does illicit drug use increase stroke risk? A systematic review, meta-analyses, and Mendelian randomization analysis"],"prefix":"10.1177","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0987-2829","authenticated-orcid":false,"given":"Megan","family":"Ritson","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-5996","authenticated-orcid":false,"given":"Hugh S","family":"Markus","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-0928","authenticated-orcid":false,"given":"Eric L","family":"Harshfield","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/17474930241308142"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2023.103677"},{"key":"e_1_3_2_4_2","unstructured":"Office for National Statistics. Drug misuse in England and Wales: year ending March 2024. Published 12 December 2024. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/crimeandjustice\/articles\/drugmisuseinenglandandwales\/yearendingmarch2024 (accessed 8 September 2025)."},{"key":"e_1_3_2_5_2","unstructured":"National Center for Drug Abuse Statistics. Drug abuse statistics. https:\/\/drugabusestatistics.org (accessed 8 September 2025)."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109132"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03391702"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.011417"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1291"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.032811"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1420675"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443532"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040501"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2017.01466"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25534"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031710"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31772-0"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.966707"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74754-1"},{"key":"e_1_3_2_21_2","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 29: 372.","journal-title":"BMJ"},{"key":"e_1_3_2_22_2","unstructured":"Wells G Shea B O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.evidencebasedpublichealth.de\/download\/Newcastle_Ottowa_Scale_Pope_Bruce.pdf (accessed 28 August 2009)."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15555.3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02653-5"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19265-z"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109667"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01563-z"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01335-3"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-023-00034-y"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0058-3"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00031-4"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.02.012"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000485098"},{"key":"e_1_3_2_35_2","first-page":"6","article-title":"Relationship of opium dependency and stroke","volume":"1","author":"Hamzei Moqaddam A","year":"2009","unstructured":"Hamzei Moqaddam A, Ahmadi Musavi SM, Khademizadeh K. Relationship of opium dependency and stroke. Addict Health 2009; 1: 6\u201310.","journal-title":"Addict Health"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1426023"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2024-325429"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091295"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648084"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165207"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-008-9025-z"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.03.019"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.4.495"},{"key":"e_1_3_2_44_2","first-page":"123","article-title":"Intracerebral and subarachnoid hemorrhage following use of methamphetamine (\u201cspeed\u201d)","volume":"53","author":"Weiss SR","year":"1970","unstructured":"Weiss SR, Raskind R, Morganstern NL, Pytlyk PJ, Baiz TC. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (\u201cspeed\u201d). Int Surg 1970; 53: 123\u2013127.","journal-title":"Int Surg"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285609347123"},{"key":"e_1_3_2_46_2","article-title":"Opium consumption prevalence among patients with ischemic stroke compared with healthy individuals in Iran","volume":"6","author":"Saberi A","year":"2017","unstructured":"Saberi A, et al. Opium consumption prevalence among patients with ischemic stroke compared with healthy individuals in Iran. Int J High Risk Behav Addict 2017; 6: e27264.","journal-title":"Int J High Risk Behav Addict"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15767"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000888"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105675"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/17474930251328524"}],"container-title":["International Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930261418926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17474930261418926","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930261418926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:15:31Z","timestamp":1782386131000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17474930261418926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/17474930261418926"],"URL":"https:\/\/doi.org\/10.1177\/17474930261418926","relation":{},"ISSN":["1747-4930","1747-4949"],"issn-type":[{"value":"1747-4930","type":"print"},{"value":"1747-4949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]}}}